The T-SPOT®.TB test is a revolutionary product that diagnoses both latent TB infection and active disease by measuring T cells that have been specifically activated by Mycobacterium tuberculosis (MTB) antigens.
The T-SPOT.TB test sets new clinical standards of sensitivity and reliability. The product was licensed across Europe in July 2004 and received FDA premarket approval in July 2008. It has been designed to replace the current tuberculin skin test (Mantoux test), bringing effective TB testing to many new patient groups where the skin test gives poor or unreliable results.
This revolutionary technology has been tested in many thousands of patients in all parts of the world. Studies have shown the excellent sensitivity and specificity of the T-SPOT.TB test and demonstrate its utility for the diagnosis and control of TB.
The T-SPOT.TB kit is supplied with a plate containing 12 X 8 well strips. 4 wells are required for each patient sample